KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Inventory Average (2016 - 2026)

Bristol Myers Squibb has reported Inventory Average over the past 17 years, most recently at $2.7 billion for Q1 2026.

  • Quarterly Inventory Average rose 4.27% to $2.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Mar 2026, up 4.27% year-over-year, with the annual reading at $2.6 billion for FY2025, 0.54% up from the prior year.
  • Inventory Average was $2.7 billion for Q1 2026 at Bristol Myers Squibb, roughly flat from $2.7 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $3.2 billion in Q3 2024 and troughed at $2.1 billion in Q1 2022.
  • The 5-year median for Inventory Average is $2.6 billion (2025), against an average of $2.6 billion.
  • Year-over-year, Inventory Average skyrocketed 33.52% in 2024 and then decreased 14.26% in 2025.
  • A 5-year view of Inventory Average shows it stood at $2.2 billion in 2022, then rose by 15.52% to $2.5 billion in 2023, then increased by 15.52% to $2.9 billion in 2024, then fell by 7.49% to $2.7 billion in 2025, then decreased by 0.04% to $2.7 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Inventory Average are $2.7 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.7 billion (Q3 2025).